144 related articles for article (PubMed ID: 34340782)
1. Nepafenac for cystoid macular oedema secondary to paclitaxel.
Tapia Quijada HE; Quijada Fumero E; Mesa Lugo FI; Serrano García M; Betancor Caro N
Arch Soc Esp Oftalmol (Engl Ed); 2021 Aug; 96(8):434-437. PubMed ID: 34340782
[TBL] [Abstract][Full Text] [Related]
2. Angiographically silent cystoid macular oedema secondary to paclitaxel therapy.
Georgakopoulos CD; Makri OE; Vasilakis P; Exarchou A
Clin Exp Optom; 2012 Mar; 95(2):233-6. PubMed ID: 22023333
[TBL] [Abstract][Full Text] [Related]
3. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
Dwivedi R; Tiroumal S
Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
[TBL] [Abstract][Full Text] [Related]
4. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients.
Warren KA; Fox JE
Retina; 2008; 28(10):1427-34. PubMed ID: 18664937
[TBL] [Abstract][Full Text] [Related]
5. Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema.
Mathys KC; Cohen KL
Eye (Lond); 2010 Jan; 24(1):90-6. PubMed ID: 19229275
[TBL] [Abstract][Full Text] [Related]
6. A case of cystoid macular edema associated with Paclitaxel chemotherapy.
Ham DS; Lee JE; Kim HW; Yun IH
Korean J Ophthalmol; 2012 Oct; 26(5):388-90. PubMed ID: 23060727
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
Tzelikis PF; Vieira M; Hida WT; Motta AF; Nakano CT; Nakano EM; Alves MR
Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061
[TBL] [Abstract][Full Text] [Related]
8. Impaired retinal pigment epithelium in paclitaxel-induced macular edema: A case report.
Shih CH; Lee YC
Medicine (Baltimore); 2018 Jun; 97(26):e11229. PubMed ID: 29952984
[TBL] [Abstract][Full Text] [Related]
9. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.
Wolf EJ; Braunstein A; Shih C; Braunstein RE
J Cataract Refract Surg; 2007 Sep; 33(9):1546-9. PubMed ID: 17720068
[TBL] [Abstract][Full Text] [Related]
10. En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography Imaging of Taxane-Associated Cystoid Macular Edema.
Sridhar J; Shahlaee A; Ehmann D; Samara WA; Rahimy E; Ho AC; Chiang A
Ophthalmic Surg Lasers Imaging Retina; 2016 Feb; 47(2):176-9. PubMed ID: 26878452
[TBL] [Abstract][Full Text] [Related]
11. Corneal melting after use of nepafenac in a patient with chronic cystoid macular edema after cataract surgery.
Di Pascuale MA; Whitson JT; Mootha VV
Eye Contact Lens; 2008 Mar; 34(2):129-30. PubMed ID: 18327052
[TBL] [Abstract][Full Text] [Related]
12. Bilateral Cystoid Macular Edema Secondary to Paclitaxel Treatment.
Tezcan Y; Surmeli M; Tastekin D; Koc M
Arch Iran Med; 2015 Sep; 18(9):606-7. PubMed ID: 26317603
[TBL] [Abstract][Full Text] [Related]
13. NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Warren KA; Bahrani H; Fox JE
Retina; 2010 Feb; 30(2):260-6. PubMed ID: 20175270
[TBL] [Abstract][Full Text] [Related]
14. Taxane Induced Cystoid Macular Edema: Case Report and Integrated Pathogenic Theory.
Kanakis M; Georgalas I; Makatsoris T; Pharmakakis N
Curr Drug Saf; 2019; 14(1):43-47. PubMed ID: 30156164
[TBL] [Abstract][Full Text] [Related]
15. Cystoid macular edema associated with iridocorneal endothelial syndrome: a case report.
Suzuki K; Mizuguchi T; Seno Y; Tanikawa A; Horiguchi M
BMC Ophthalmol; 2016 Sep; 16(1):155. PubMed ID: 27585567
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory Medication of Cataract Surgery in Pseudoexfoliation Syndrome - NSAID Is Needed.
Ilveskoski L; Taipale C; Tuuminen R
Curr Eye Res; 2020 Jul; 45(7):814-819. PubMed ID: 31801388
[TBL] [Abstract][Full Text] [Related]
17. Nab-Paclitaxel related cystoid macular edema.
Di Pippo M; Di Staso F; De Ponte C; Fragiotta S; Abdolrahimzadeh S
Clin Ter; 2022; 173(4):377-383. PubMed ID: 35857057
[TBL] [Abstract][Full Text] [Related]
18. The mystery of angiographically silent macular oedema due to taxanes.
Kuznetcova TI; Cech P; Herbort CP
Int Ophthalmol; 2012 Jun; 32(3):299-304. PubMed ID: 22484725
[TBL] [Abstract][Full Text] [Related]
19. Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy.
Nomi N; Ota M; Fukumura M; Nuno Y; Hatano M; Wakuta M; Yanai R; Kimura K
Jpn J Ophthalmol; 2018 Mar; 62(2):163-167. PubMed ID: 29270811
[TBL] [Abstract][Full Text] [Related]
20. Cystoid Macular Edema Due to Accidental Latanoprost Overdose After Uncomplicated Phacoemulsification.
Makri OE; Tsekouras IK; Plotas P; Tsapardoni F; Pallikari A; Georgakopoulos CD
Curr Drug Saf; 2018; 13(3):208-210. PubMed ID: 29921209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
